Virtual Cells Transform Biology
Summary:
AI-powered virtual cells could revolutionise biology, shifting from 90% experimental to 90% computational work, though critics cite hype over concrete results.
Amgen’s Cancer Drug Success
Summary:
Bemarituzumab combined with chemotherapy significantly improved survival in gastric cancer patients, despite eye-related side effects in Phase III trial.
Scientific Academy Under Siege
Summary:
Trump administration cuts force US National Academies into crisis, with budget slashes, staff layoffs, and censorship accusations over diversity research bans.
AbbVie’s £2.1bn Cell Therapy Bet
Summary:
AbbVie acquires Capstan Therapeutics for up to $2.1bn, gaining access to revolutionary in-vivo CAR-T technology using lipid nanoparticles and mRNA.
Peer Review Gets Democratic Makeover
Summary:
Distributed peer review trials show promise, cutting funding decisions from months to weeks whilst democratising reviews, though expertise concerns remain.
